Acurx Pharmaceuticals Inc
NASDAQ:ACXP
Income Statement
Earnings Waterfall
Acurx Pharmaceuticals Inc
Revenue
|
0
USD
|
Operating Expenses
|
-14.6m
USD
|
Operating Income
|
-14.6m
USD
|
Other Expenses
|
0
USD
|
Net Income
|
-14.6m
USD
|
Income Statement
Acurx Pharmaceuticals Inc
Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||
Operating Expenses |
(5)
|
(5)
|
(8)
|
(11)
|
(13)
|
(14)
|
(13)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(15)
|
|
Selling, General & Administrative |
(2)
|
(3)
|
(7)
|
(10)
|
(11)
|
(11)
|
(9)
|
(7)
|
(7)
|
(7)
|
(7)
|
(7)
|
(9)
|
|
Research & Development |
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(6)
|
|
Operating Income |
(5)
N/A
|
(5)
-4%
|
(8)
-66%
|
(11)
-42%
|
(13)
-14%
|
(14)
-9%
|
(13)
+10%
|
(11)
+9%
|
(12)
-5%
|
(12)
-2%
|
(13)
-7%
|
(13)
+3%
|
(15)
-15%
|
|
Pre-Tax Income | ||||||||||||||
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(5)
N/A
|
(5)
-4%
|
(8)
-65%
|
(11)
-42%
|
(13)
-14%
|
(14)
-9%
|
(13)
+10%
|
(11)
+9%
|
(12)
-5%
|
(12)
-2%
|
(13)
-7%
|
(13)
+3%
|
(15)
-15%
|
|
Net Income | ||||||||||||||
Income from Continuing Operations |
(5)
|
(5)
|
(8)
|
(11)
|
(13)
|
(14)
|
(13)
|
(11)
|
(12)
|
(12)
|
(13)
|
(13)
|
(15)
|
|
Net Income (Common) |
(5)
N/A
|
(5)
-4%
|
(8)
-65%
|
(11)
-42%
|
(13)
-14%
|
(14)
-9%
|
(13)
+10%
|
(11)
+9%
|
(12)
-5%
|
(12)
-2%
|
(13)
-7%
|
(13)
+3%
|
(15)
-15%
|
|
EPS (Diluted) |
-0.48
N/A
|
-0.5
-4%
|
-1.12
-124%
|
-1.1
+2%
|
-1.49
-35%
|
-1.36
+9%
|
-1.24
+9%
|
-1.02
+18%
|
-1.12
-10%
|
-1.05
+6%
|
-1.07
-2%
|
-0.97
+9%
|
-1.15
-19%
|